7 September 2021 in Epilepsia
Summary: Objective: Patients with absence epilepsy sensitivity <10% of their absences. The clinical gold standard to assess absence epilepsy is a 24‐h electroencephalographic (EEG) recording, which is expensive, obtrusive, and time‐consuming to review. We aimed to (1) investigate the performance of an unobtrusive, two‐channel behind‐the‐ear EEG‐based wearable, the Sensor Dot (SD), to detect typical absences in adults and children; and (2) develop a sensitive patient‐specific absence seizure detection algorithm to reduce the review time of the recordings.Methods: We recruited 12 patients (median age = 21 years, range = 8–50; seven female) who were admitted to the epilepsy monitoring units of University Hospitals Leuven for a 24‐h 25‐channel video‐EEG recording to assess their refractory typical absences. Four additional behind‐the‐ear electrodes were attached for concomitant recording with the SD. Typical absences were defined as 3‐Hz spike‐and‐wave discharges on EEG, lasting 3 s or longer. Seizures on SD were blindly annotated on the full recording and on the algorithm‐labeled file and consequently compared to 25‐channel EEG annotations. Patients or caregivers were asked to keep a seizure diary. Performance of the SD and seizure diary were measured using the F1 score.Results: We concomitantly recorded 284 absences on video‐EEG and SD. Our absence detection algorithm had a sensitivity of .983 and false positives per hour rate of .9138. Blind reading of full SD data resulted in sensitivity of .81, precision of .89, and F1 score of .73, whereas review of the algorithm‐labeled files resulted in scores of .83, .89, and .87, respectively. Patient self‐reporting gave sensitivity of .08, precision of 1.00, and F1 score of .15.Significance: Using the wearable SD, epileptologists were able to reliably detect typical absence seizures. Our automated absence detection algorithm reduced the review time of a 24‐h recording from 1‐2 h to around 5–10 min.
3 February 2023 in Epilepsia
Objective: The aim is to report the performance of an electroencephalogram (EEG) seizure‐detector algorithm on data obtained with a wearable device (WD) in patients with focal refractory epilepsy and their experience.Methods: Patients used a WD, the Sensor Dot (SD), to measure two channels of EEG using dry electrode patches during presurgical evaluation and at home for up to 8 months. An automated seizure detection algorithm flagged EEG regions with possible seizures, which we reviewed to evaluate the algorithm's diagnostic yield. In addition, we collected data on usability, side effects, and patient satisfaction with an electronic seizure diary application (Helpilepsy).Results: Sixteen inpatients used the SD for up to 5 days and had 21 seizures. Sixteen outpatients used the device for up to 8 months and reported 101 focal impaired awareness seizures during the periods selected for analysis. Focal seizure detection sensitivity based on behind‐the‐ear EEG was 52% in inpatients and 23% in outpatients. False detections/h, positive predictive value (PPV), and F1 scores were 7.13%, .11%, and .002% for inpatients and 7.77%, .04%, and .001% for outpatients. Artifacts and low signal quality contributed to poor performance metrics. The seizure detector identified 19 nonreported seizures during sleep, when the signal quality was better. Regarding patients' experience, the likelihood of using the device at 6 months was 62%, and side effects were the main reason for dropping out. Finally, daily and monthly questionnaire completion rates were 33% and 65%, respectively.Significance: Focal seizure detection sensitivity based on behind‐the‐ear EEG was 52% in inpatients and 23% in outpatients, with high false alarm rates and low PPV and F1 scores. This unobtrusive wearable seizure detection device was well received but had side effects. The current workflow and low performance limit its implementation in clinical practice. We suggest different steps to improve these performance metrics and patient experience.
6 September 2023 in Epilepsia
3 April 2025 in Journal of Sleep Research
Automated sleep staging on wearable data could improve our understanding and management of epilepsy. This study evaluated sleep scoring by a deep learning model on 223 night‐sleep recordings from 50 patients measured in the hospital with an electroencephalogram (EEG) and a wearable device. The model scored the sleep stage of every 30‐s epoch on the EEG and wearable data, and we compared the output with a clinical expert on 20 nights, each for a different patient. The Bland–Altman analysis examined differences in the automated staging in both modalities, and using mixed‐effect models, we explored sleep differences between patients with and without seizures. Overall, we found moderate accuracy and Cohen's kappa on the model scoring of standard EEG (0.73 and 0.59) and the wearable (0.61 and 0.43) versus the clinical expert. F1 scores also varied between patients and the modalities. The sensitivity varied by sleep stage and was very low for stage N1. Moreover, sleep staging on the wearable data underestimated the duration of most sleep macrostructure parameters except N2. On the other hand, patients with seizures during the hospital admission slept more each night (6.37, 95% confidence interval [CI] 5.86–7.87) compared with patients without seizures (5.68, 95% CI 5.24–6.13), p = 0.001, but also spent more time in stage N2. In conclusion, wearable EEG and accelerometry could monitor sleep in patients with epilepsy, and our approach can help automate the analysis. However, further steps are essential to improve the model performance before clinical implementation. Trial Registration: The SeizeIT2 trial was registered in clinicaltrials.gov, NCT04284072